MARKER THERAPEUTICS, INC. Cash Provided by (Used in) Discontinued Operations, Operating Activities (Deprecated 2009-01-31)
MARKER THERAPEUTICS, INC. (MRKR) reported Cash Provided by (Used in) Discontinued Operations, Operating Activities (Deprecated 2009-01-31) of -$16.42 million for the 161-month period ending 2012-12-31, per its 10-K filed 2013-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInDiscontinuedOperationsOperatingActivities · last filed 2013-05-15
- MARKER THERAPEUTICS, INC. cash provided by (used in) discontinued operations, operating activities (deprecated 2009-01-31) for fiscal 2012 was -$1.57M.
- MARKER THERAPEUTICS, INC. cash provided by (used in) discontinued operations, operating activities (deprecated 2009-01-31) for fiscal 2011 was -$1.31M.
| Period end | Cash Provided by (Used in) Discontinued Operations, Operating Activities (Deprecated 2009-01-31) 12 month | Cash Provided by (Used in) Discontinued Operations, Operating Activities (Deprecated 2009-01-31) 161 month |
|---|---|---|
| 2012-12-31 | -$1.57M 10-K · filed 2013-05-15 | -$16.42M 10-K · filed 2013-05-15 |
| 2011-12-31 | -$1.31M 10-K · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |